Walgreens Boots Alliance sold its remaining shares of Option Care Health Thursday for more than $330 million marking an end to its stake in the company.
The drugstore chain will devote the proceeds from selling 10.8 million shares of what used to be known as Walgreens Infusion Services to reducing its debt, the company said in a news release Thursday. Walgreens Boots has been slowly selling off Option Care stock. In March, the company sold 15.5 million shares of Option Care for $30.75 per share.
The transaction took place less than a month after Option Care announced plans to acquire Amedisys for $3.6 billion, although UnitedHealth Group’s Optum is also vying for for the company.
Walgreens shares closed at $31.85 on the Nasdaq Stock Exchange Thursday, down 2.5% from the opening price. The company’s stock opened at $31.78 on Friday.
